Perceptive Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Perceptive Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,113	Closed	-$43K	–	228
2016 Q2	$43K	Buy	+1,113	New	+$46.2K	﹤0.01%	161
2015 Q1	–	Sell	-50,000	Closed	-$2.61M	–	191
2014 Q4	$2.61M	Buy	+50,000	New	+$2.24M	0.22%	79

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Perceptive Advisors's JUNO Position: Q3 2016 in Review

Perceptive Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2016, closing a stake of 1,113 shares — an estimated $43K sold.

Perceptive Advisors first reported a position in JUNO in Q4 2014 and held it in 2 quarters. The position peaked at $2.61M in Q4 2014. 169 funds tracked by Wall St. Rank hold JUNO as of Q3 2016.

Perceptive Advisors reported no remaining Juno Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
Perceptive Advisors sold 1,113 Juno Therapeutics, Inc. shares in Q3 2016, an estimated $43K.
Perceptive Advisors first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 2 quarters.
Perceptive Advisors's Juno Therapeutics, Inc. position peaked at $2.61M in Q4 2014.
169 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2016.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.